GNTA Genenta Science S.p.A.
Healthcare$0.60+3.00%ClosedMarket Cap: $11.4M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
0.48
P/S
0.00
EV/EBITDA
-1.84
DCF Value
$-0.13
FCF Yield
-80.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-36.8%
ROA
-19.6%
ROIC
-21.3%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 null | $0.00 | -Infinity% | $-3.2M | $-2.7M | $— | — |
| FY null | $0.00 | -Infinity% | $-6.3M | $-6.3M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-3.2M | $-3.6M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-5.5M | $-5.1M | $— | — |
| FY null | $0.00 | -Infinity% | $-10.2M | $-9.3M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-4.6M | $-4.1M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-4.8M | $-4.8M | $— | — |
| FY null | $0.00 | -Infinity% | $-11.5M | $-11.4M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-6.7M | $-6.7M | $— | — |
| Q4 null | $0.00 | NaN% | $-6.9M | $-6.4M | $— | — |
| FY null | $0.00 | -Infinity% | $-10.8M | $-8.3M | $— | — |
| Q2 null | $0.00 | NaN% | $-4.2M | $-2.1M | $— | — |